Yin-Ching Iris Chen, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Polymers | 1 | 2024 | 1627 | 0.560 |
Why?
|
| Receptors, Dopamine | 4 | 2006 | 293 | 0.460 |
Why?
|
| Dopamine | 7 | 2006 | 1592 | 0.330 |
Why?
|
| Magnetic Resonance Imaging | 18 | 2024 | 36743 | 0.290 |
Why?
|
| Tomography, Emission-Computed | 8 | 2004 | 1126 | 0.240 |
Why?
|
| Theobromine | 1 | 2005 | 14 | 0.240 |
Why?
|
| Microdialysis | 3 | 2005 | 156 | 0.240 |
Why?
|
| Receptors, Dopamine D3 | 1 | 2005 | 107 | 0.240 |
Why?
|
| Brain | 16 | 2024 | 27366 | 0.240 |
Why?
|
| Receptor, Adenosine A2A | 1 | 2005 | 129 | 0.230 |
Why?
|
| Receptors, Dopamine D2 | 3 | 2005 | 471 | 0.230 |
Why?
|
| Ferric Compounds | 2 | 2005 | 376 | 0.220 |
Why?
|
| Brain Mapping | 8 | 2006 | 6685 | 0.220 |
Why?
|
| Rats | 18 | 2024 | 23751 | 0.200 |
Why?
|
| Electrodes | 1 | 2024 | 617 | 0.190 |
Why?
|
| Dopamine Uptake Inhibitors | 5 | 2005 | 287 | 0.190 |
Why?
|
| Behavior, Animal | 3 | 2004 | 1861 | 0.190 |
Why?
|
| Rats, Sprague-Dawley | 13 | 2006 | 8120 | 0.160 |
Why?
|
| Cell Transplantation | 2 | 2002 | 475 | 0.150 |
Why?
|
| Cocaine | 5 | 2004 | 947 | 0.140 |
Why?
|
| Cerebrovascular Circulation | 8 | 2006 | 2726 | 0.140 |
Why?
|
| Amphetamine | 5 | 2005 | 222 | 0.130 |
Why?
|
| Huntington Disease | 5 | 2003 | 1147 | 0.130 |
Why?
|
| Rhodopsin | 1 | 2015 | 202 | 0.120 |
Why?
|
| Eye Injuries | 1 | 2015 | 228 | 0.100 |
Why?
|
| Corpus Striatum | 4 | 2006 | 1225 | 0.100 |
Why?
|
| Dextroamphetamine | 2 | 2005 | 132 | 0.090 |
Why?
|
| Drug Interactions | 2 | 2005 | 1419 | 0.090 |
Why?
|
| Magnetic Resonance Spectroscopy | 8 | 2004 | 3780 | 0.090 |
Why?
|
| Parkinson Disease, Secondary | 2 | 2003 | 120 | 0.080 |
Why?
|
| Retinal Diseases | 1 | 2015 | 710 | 0.080 |
Why?
|
| Trinucleotide Repeats | 2 | 2001 | 257 | 0.080 |
Why?
|
| Dopamine Agents | 3 | 2004 | 188 | 0.080 |
Why?
|
| Neurons | 4 | 2015 | 9518 | 0.080 |
Why?
|
| Animals | 22 | 2024 | 169225 | 0.070 |
Why?
|
| 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 2 | 2004 | 89 | 0.070 |
Why?
|
| Oxidopamine | 4 | 2002 | 169 | 0.070 |
Why?
|
| Thalamus | 2 | 2006 | 1047 | 0.070 |
Why?
|
| Ischemia | 1 | 2015 | 1901 | 0.070 |
Why?
|
| Neostriatum | 3 | 2004 | 236 | 0.070 |
Why?
|
| Salicylamides | 1 | 2005 | 31 | 0.060 |
Why?
|
| Quinpirole | 1 | 2005 | 27 | 0.060 |
Why?
|
| Dopamine Agonists | 2 | 2005 | 347 | 0.060 |
Why?
|
| Adenosine A2 Receptor Antagonists | 1 | 2005 | 50 | 0.060 |
Why?
|
| Neuroprotective Agents | 2 | 2003 | 958 | 0.060 |
Why?
|
| Dopamine Antagonists | 1 | 2005 | 284 | 0.060 |
Why?
|
| Nicotinic Agonists | 1 | 2006 | 265 | 0.060 |
Why?
|
| Contrast Media | 3 | 2015 | 5331 | 0.050 |
Why?
|
| Propionates | 1 | 2004 | 180 | 0.050 |
Why?
|
| Lactic Acid | 5 | 2004 | 1140 | 0.050 |
Why?
|
| Blood Volume | 1 | 2005 | 545 | 0.050 |
Why?
|
| Sympathectomy, Chemical | 2 | 2000 | 25 | 0.050 |
Why?
|
| Hemodynamics | 3 | 2006 | 4194 | 0.050 |
Why?
|
| Oxides | 1 | 2004 | 403 | 0.050 |
Why?
|
| Avian Proteins | 1 | 2002 | 77 | 0.050 |
Why?
|
| Adrenergic Agents | 2 | 2002 | 72 | 0.050 |
Why?
|
| Parkinsonian Disorders | 1 | 2004 | 285 | 0.050 |
Why?
|
| Nicotine | 1 | 2006 | 680 | 0.050 |
Why?
|
| Basal Ganglia | 2 | 2000 | 553 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 2001 | 377 | 0.040 |
Why?
|
| Motor Activity | 4 | 2004 | 2711 | 0.040 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2004 | 302 | 0.040 |
Why?
|
| Substantia Nigra | 1 | 2002 | 346 | 0.040 |
Why?
|
| Striatonigral Degeneration | 1 | 1999 | 13 | 0.040 |
Why?
|
| Neurotoxins | 2 | 1997 | 240 | 0.040 |
Why?
|
| Riluzole | 1 | 1999 | 62 | 0.040 |
Why?
|
| Brain Chemistry | 2 | 2003 | 958 | 0.040 |
Why?
|
| Energy Metabolism | 5 | 2004 | 2908 | 0.040 |
Why?
|
| Oxygen | 3 | 2005 | 4269 | 0.040 |
Why?
|
| Encephalitis | 1 | 2002 | 441 | 0.040 |
Why?
|
| Iodoacetates | 1 | 1997 | 17 | 0.040 |
Why?
|
| Antigens, Surface | 1 | 2002 | 1617 | 0.040 |
Why?
|
| Neural Pathways | 3 | 2006 | 3113 | 0.030 |
Why?
|
| Time Factors | 5 | 2005 | 40210 | 0.030 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 1999 | 451 | 0.030 |
Why?
|
| Blood Proteins | 1 | 2002 | 1191 | 0.030 |
Why?
|
| Iron | 1 | 2004 | 1813 | 0.030 |
Why?
|
| Embryo, Mammalian | 1 | 2002 | 1676 | 0.030 |
Why?
|
| Membrane Glycoproteins | 2 | 2003 | 3710 | 0.030 |
Why?
|
| Nerve Degeneration | 4 | 2003 | 749 | 0.030 |
Why?
|
| Pain Threshold | 1 | 1999 | 607 | 0.030 |
Why?
|
| Acupuncture Therapy | 1 | 1999 | 486 | 0.030 |
Why?
|
| Glucose | 3 | 2004 | 4351 | 0.030 |
Why?
|
| Antigens, Neoplasm | 1 | 2002 | 1997 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2005 | 10757 | 0.030 |
Why?
|
| Microglia | 1 | 2002 | 1376 | 0.030 |
Why?
|
| Motor Cortex | 1 | 2000 | 1013 | 0.030 |
Why?
|
| Psychomotor Performance | 1 | 2000 | 1892 | 0.020 |
Why?
|
| Macaca fascicularis | 2 | 2004 | 912 | 0.020 |
Why?
|
| Ischemic Attack, Transient | 1 | 1997 | 877 | 0.020 |
Why?
|
| Carbon Radioisotopes | 2 | 2003 | 567 | 0.020 |
Why?
|
| Sympatholytics | 2 | 2002 | 82 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2002 | 4035 | 0.020 |
Why?
|
| Carotid Arteries | 1 | 2015 | 942 | 0.020 |
Why?
|
| Parkinson Disease | 2 | 2002 | 2893 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2003 | 4414 | 0.020 |
Why?
|
| Male | 17 | 2015 | 364638 | 0.020 |
Why?
|
| Reperfusion Injury | 1 | 1997 | 1041 | 0.020 |
Why?
|
| Neurodegenerative Diseases | 1 | 1999 | 1095 | 0.020 |
Why?
|
| Cerebral Cortex | 1 | 2006 | 5814 | 0.020 |
Why?
|
| Stem Cells | 1 | 2002 | 3537 | 0.020 |
Why?
|
| Sensitivity and Specificity | 2 | 2004 | 14718 | 0.020 |
Why?
|
| Radioligand Assay | 1 | 2004 | 366 | 0.010 |
Why?
|
| Nitro Compounds | 1 | 2004 | 74 | 0.010 |
Why?
|
| Acetylcholine | 1 | 2006 | 628 | 0.010 |
Why?
|
| Cerebral Arteries | 1 | 2006 | 490 | 0.010 |
Why?
|
| Humans | 8 | 2024 | 767998 | 0.010 |
Why?
|
| Succinic Acid | 1 | 2004 | 86 | 0.010 |
Why?
|
| Ferrosoferric Oxide | 1 | 2004 | 348 | 0.010 |
Why?
|
| Choline | 1 | 2004 | 522 | 0.010 |
Why?
|
| Brain Ischemia | 1 | 2015 | 3007 | 0.010 |
Why?
|
| Isotope Labeling | 1 | 2003 | 394 | 0.010 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2003 | 417 | 0.010 |
Why?
|
| Gliosis | 1 | 2002 | 246 | 0.010 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2002 | 367 | 0.010 |
Why?
|
| Tobacco Use Disorder | 1 | 2006 | 708 | 0.010 |
Why?
|
| Isoquinolines | 1 | 2002 | 354 | 0.010 |
Why?
|
| Apomorphine | 1 | 2000 | 148 | 0.010 |
Why?
|
| Reaction Time | 1 | 2006 | 2098 | 0.010 |
Why?
|
| Stereotyped Behavior | 1 | 2000 | 133 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2003 | 1533 | 0.010 |
Why?
|
| Toes | 1 | 2000 | 209 | 0.010 |
Why?
|
| Acupuncture Analgesia | 1 | 1999 | 63 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2003 | 2299 | 0.010 |
Why?
|
| Saccades | 1 | 2000 | 235 | 0.010 |
Why?
|
| Acupuncture Points | 1 | 1999 | 111 | 0.010 |
Why?
|
| Chorea | 1 | 1999 | 80 | 0.010 |
Why?
|
| Rotation | 1 | 2000 | 517 | 0.010 |
Why?
|
| Models, Structural | 1 | 1998 | 340 | 0.010 |
Why?
|
| Atrophy | 1 | 2003 | 1646 | 0.010 |
Why?
|
| Iodoacetic Acid | 1 | 1997 | 11 | 0.010 |
Why?
|
| NADPH Dehydrogenase | 1 | 1997 | 43 | 0.010 |
Why?
|
| Membrane Transport Proteins | 1 | 2003 | 1037 | 0.010 |
Why?
|
| Fingers | 1 | 2000 | 511 | 0.010 |
Why?
|
| Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 1997 | 79 | 0.010 |
Why?
|
| Cyclic N-Oxides | 1 | 1997 | 71 | 0.010 |
Why?
|
| Occipital Lobe | 1 | 1999 | 376 | 0.010 |
Why?
|
| Partial Pressure | 1 | 1997 | 248 | 0.010 |
Why?
|
| Oxygen Consumption | 1 | 2003 | 1880 | 0.010 |
Why?
|
| Nitrogen Oxides | 1 | 1997 | 128 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2015 | 22381 | 0.010 |
Why?
|
| Oxidative Stress | 2 | 1999 | 3140 | 0.010 |
Why?
|
| Oxidative Phosphorylation | 1 | 1999 | 501 | 0.010 |
Why?
|
| Neurochemistry | 1 | 1996 | 29 | 0.010 |
Why?
|
| Electron Transport Complex II | 1 | 1996 | 53 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2004 | 6225 | 0.010 |
Why?
|
| Artifacts | 1 | 2004 | 1923 | 0.010 |
Why?
|
| Disease Progression | 2 | 2004 | 13667 | 0.010 |
Why?
|
| Spin Labels | 1 | 1997 | 336 | 0.010 |
Why?
|
| Succinate Dehydrogenase | 1 | 1996 | 148 | 0.010 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2004 | 2054 | 0.010 |
Why?
|
| Lactates | 1 | 1996 | 401 | 0.010 |
Why?
|
| Single-Blind Method | 1 | 1999 | 1587 | 0.010 |
Why?
|
| Hand | 1 | 2000 | 913 | 0.010 |
Why?
|
| Magnetics | 1 | 1998 | 597 | 0.010 |
Why?
|
| Ultrasonography, Doppler | 1 | 1997 | 463 | 0.010 |
Why?
|
| Ligands | 1 | 2002 | 3284 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 2002 | 1667 | 0.010 |
Why?
|
| Female | 7 | 2003 | 397102 | 0.010 |
Why?
|
| Oxidoreductases | 1 | 1996 | 410 | 0.010 |
Why?
|
| Glycolysis | 1 | 1998 | 837 | 0.010 |
Why?
|
| Reproducibility of Results | 2 | 2003 | 20218 | 0.010 |
Why?
|
| Functional Laterality | 1 | 2000 | 2263 | 0.010 |
Why?
|
| Aspartic Acid | 1 | 1996 | 577 | 0.010 |
Why?
|
| Regional Blood Flow | 1 | 1997 | 1498 | 0.010 |
Why?
|
| Acute Disease | 1 | 2004 | 7241 | 0.010 |
Why?
|
| Body Weight | 1 | 2004 | 4628 | 0.010 |
Why?
|
| Case-Control Studies | 2 | 2003 | 22286 | 0.010 |
Why?
|
| Protons | 1 | 1998 | 1114 | 0.010 |
Why?
|
| Multienzyme Complexes | 1 | 1996 | 664 | 0.010 |
Why?
|
| Carbon Dioxide | 1 | 1997 | 1148 | 0.010 |
Why?
|
| Adult | 6 | 2003 | 223577 | 0.010 |
Why?
|
| Glutamic Acid | 1 | 1997 | 1189 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2004 | 9384 | 0.010 |
Why?
|
| Mice | 1 | 2015 | 82024 | 0.000 |
Why?
|
| Immunohistochemistry | 1 | 2002 | 11068 | 0.000 |
Why?
|
| Linear Models | 1 | 1998 | 5883 | 0.000 |
Why?
|
| Positron-Emission Tomography | 1 | 2004 | 6668 | 0.000 |
Why?
|
| Middle Aged | 4 | 2003 | 223422 | 0.000 |
Why?
|
| Pilot Projects | 1 | 1999 | 8740 | 0.000 |
Why?
|
| Heart Rate | 1 | 1997 | 4215 | 0.000 |
Why?
|
| Disease Models, Animal | 1 | 2004 | 18345 | 0.000 |
Why?
|
| Blood Pressure | 1 | 1997 | 8539 | 0.000 |
Why?
|
| Severity of Illness Index | 1 | 1999 | 15944 | 0.000 |
Why?
|
| Follow-Up Studies | 1 | 2001 | 39340 | 0.000 |
Why?
|
| Antineoplastic Agents | 1 | 2002 | 13658 | 0.000 |
Why?
|
| Aging | 1 | 1996 | 8745 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 1999 | 65360 | 0.000 |
Why?
|